IDH3A and glioblastoma: It was reported that isocitrate dehydrogenase (IDH) mutant glioblastoma, which represents a minority of patients with glioblastoma (approximately 10%) and is more commonly diagnosed in younger patients, preferentially locates at frontal lobe [26, 27].